CHNR - China Natural Resou... Stock Analysis | Stock Taper
Logo
China Natural Resources, Inc.

CHNR

China Natural Resources, Inc. NASDAQ
$3.82 1.60% (+0.06)

Market Cap $4.72 M
52w High $8.20
52w Low $3.16
P/E -54571.43
Volume 1.19K
Outstanding Shares 1.26M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $0 $152.13K $42.2K 0% $0.03 $-152.13K
Q2-2025 $0 $3.1M $-1.26M 0% $-1 $-1.25M
Q4-2024 $0 $-1.99M $57.84K 0% $-0.32 $2.34M
Q2-2024 $0 $2M $-61K 0% $-0.01 $-2M
Q4-2023 $0 $8M $-3.1M 0% $-3.71 $-7.45M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $475.3K $247.34M $160.96M $86.38M
Q2-2025 $726.83K $251.45M $164.98M $86.47M
Q4-2024 $3.08M $260.89M $172.83M $88.06M
Q2-2024 $4.76M $253.81M $177.81M $76M
Q4-2023 $4.76M $253.81M $177.81M $76M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $42.2K $-1.6M $49.08K $-2.37M $-234.15K $-1.6M
Q2-2025 $-1.26M $-4.11M $0 $2.1M $-2.3M $-4.11M
Q4-2024 $-3.16M $-7.41M $1K $15.1M $-1.67M $-7.41M
Q2-2024 $-122 $-11.93M $-4.03K $7.92M $-23.44M $-11.85K
Q4-2023 $-526.59K $1.45M $2.44K $-5.13M $-26.94M $1.45M

5-Year Trend Analysis

A comprehensive look at China Natural Resources, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Key positives include a debt‑free balance sheet, ample short‑term liquidity, and a diversified set of assets across mining, prospective lithium exposure, AI hardware, and healthcare opportunities. The company’s willingness to pivot and pursue new technologies, particularly physical AI and AI‑enabled operations, shows strategic flexibility. If even part of this portfolio begins to generate sustainable revenue, CHNR could benefit from exposure to several structurally growing themes.

! Risks

The main risks are severe and immediate: business revenues have effectively disappeared, operating losses and cash burn are significant, and retained earnings are heavily negative. Execution and integration risk around acquisitions is high, especially as CHNR moves into highly competitive and technically complex fields such as AI and healthcare where it lacks a long track record. Prolonged losses could eventually erode its liquidity cushion and force difficult choices around raising capital, shrinking the business, or restructuring.

Outlook

The outlook is highly uncertain and depends on whether CHNR can successfully convert its strategic pivot into real, recurring revenue while tightening its cost structure. In the near term, financial performance is likely to remain weak as the company completes acquisitions and tries to ramp new products and services. Over the longer term, outcomes could range from a successful multi‑sector platform with innovative AI and healthcare offerings to continued financial strain if commercialization falls short. Monitoring progress on revenue recovery, cash burn, and concrete milestones in AI, healthcare, and mining projects will be critical to assessing how this trajectory evolves.